Inactivating mutations in the SMARCB1 (INI1) and SMARCB4 genes were recently described in a subset of soft tissue tumors with epithelioid or rhabdoid cell features [13,14,15]. The gene discussed is SMARCB1; the disease is soft tissue neoplasm.